Analytical Reports on Valeant Pharmaceuticals International and Elan Corp. plc - High Volatility Seen in Many Drug Delivery Companies
(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 08/02/11 -- provides members with proprietary analysis of over 10,000 stocks which is updated every day. Today, members can receive their complimentary stock analysis on (NYSE: VRX) and (NYSE: ELN). Sign up now on to get your free reports on these stocks.
For many companies in the Healthcare Drug Delivery Sector, 2011 has been a year of tremendous growth. Companies in the sector such as Valeant Pharmaceuticals International and Elan Corp. plc have both substantially increased their stock prices over the last year. gives traders a unique insight about and by registering now at
or
.
The pharmaceuticals industry can be very volatile though, as issues with drug side effects can quickly take profitable drugs off the market. One such example is Elan's multiple sclerosis drug Tysabri which was temporarily taken off the market in 2005 after being tied to a possibly fatal brain disorder. Now that tests have been created to test patients' susceptibility to the disorder, sales of Tysabri have once again taken off and are driving profits for Elan.
brings investors free classic analysis on Valeant Pharmaceuticals International, Elan Corp. plc and other companies within the Drug Delivery industry. This type of analysis is only a fragment of the information members have available to them. To learn more we encourage investors to sign up at .
Another issue that many drug makers have to deal with is the expiration of their drug patents. Many high profile drugs could be going generic this year alone, and looking out for the companies that produce the name brand drugs as well as the generic versions of those drugs could be a key to success for investors.
Signal Watch's #1 goal is to help customers successfully engage the markets. For over 20 years, we have been developing the most powerful trading software available anywhere. But the software is only part of our mission. We also provide education and customer support designed to enable our customers to take control of their financial future.
Read our disclaimer by clicking on the following link
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 02.08.2011 - 06:53 Uhr
Sprache: Deutsch
News-ID 1026590
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
NEW YORK, NY
Phone:
Kategorie:
Commercial & Investment Banking
Anmerkungen:
Diese Pressemitteilung wurde bisher 102 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Analytical Reports on Valeant Pharmaceuticals International and Elan Corp. plc - High Volatility Seen in Many Drug Delivery Companies
"
steht unter der journalistisch-redaktionellen Verantwortung von
Signal Watch (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
